Renafor-B Inhalation Capsule is a dry-powder inhalation therapy combining Budesonide and Formoterol Fumarate, designed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). This combination provides both anti-inflammatory action and bronchodilation, helping patients maintain open airways and reduce symptoms such as wheezing, shortness of breath, and coughing.

• Budesonide, an inhaled corticosteroid, targets airway inflammation, reduces swelling, and prevents mucus accumulation.

• Formoterol Fumarate, a long-acting beta-2 agonist (LABA), relaxes the smooth muscles of the airways, ensuring sustained bronchodilation and improved airflow.

Renafor-B Inhalation Capsules offer convenient, precise dosing via a dry-powder inhaler, suitable for patients who require consistent daily therapy for better control of persistent asthma or COPD.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each inhalation capsule contains:

• Budesonide – 100 mcg

• Formoterol Fumarate – 6 mcg

Mechanism of Action

Renafor-B works through the synergistic actions of its components:

• Budesonide: Reduces inflammation in the bronchial tubes by inhibiting inflammatory cells and mediators, preventing airway swelling and mucus buildup.

• Formoterol Fumarate: Stimulates beta-2 adrenergic receptors in airway smooth muscle, causing long-acting bronchodilation, which facilitates airflow and relieves breathing difficulty.

Together, these mechanisms provide both immediate symptom relief and long-term prevention of asthma or COPD exacerbations.

Indications

Renafor-B Inhalation Capsule is indicated for:

• Maintenance therapy for persistent asthma

• Management of moderate to severe COPD

• Prevention of asthma and COPD exacerbations

• Patients requiring combination therapy for long-term airway control

This medication is not intended for acute symptom relief; a short-acting rescue inhaler should be used for sudden attacks.

Dosage and Administration

The exact dosage should be prescribed by a healthcare professional. General instructions include:

• Typical dose: 1 capsule inhaled twice daily, or as directed by a physician

• Insert the capsule into the dry-powder inhaler device

• Exhale fully, place the mouthpiece in the mouth, and inhale deeply to ensure the full dose reaches the lungs

• Hold your breath for 5–10 seconds, then exhale slowly

• Do not swallow the capsule; it is for inhalation only

Rinsing the mouth after inhalation is recommended to reduce the risk of oral thrush caused by Budesonide.

Possible Side Effects

Common side effects may include:

• Throat irritation or hoarseness

• Cough

• Dry mouth

• Headache

• Tremors or palpitations

Serious side effects, though rare, may include:

• Allergic reactions

• Worsening respiratory symptoms

• Increased heart rate or arrhythmias

Seek medical advice if severe or persistent symptoms occur.

Precautions and Warnings

• Inform your doctor about heart disease, high blood pressure, thyroid disorders, or seizures

• Not suitable as a rescue inhaler for sudden asthma attacks

• Regular lung function monitoring may be necessary for long-term use

• Use caution during pregnancy or breastfeeding and only under medical supervision

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 30°C in a dry place

• Keep capsules in the blister until ready to use

• Protect from moisture and direct sunlight

• Keep out of reach of children

Conclusion

Renafor-B Inhalation Capsule 100/6 mcg (Budesonide + Formoterol Fumarate) is a dry-powder inhalation therapy for long-term management of asthma and COPD. By combining anti-inflammatory and bronchodilator effects, it helps prevent exacerbations, improve breathing, and maintain lung function. Proper use under medical supervision ensures effective and safe treatment of chronic respiratory conditions.